185 related articles for article (PubMed ID: 10803634)
21. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
Radecke K; Frühauf NR; Miller M; Ross B; Köditz R; Malagó M; Broelsch CE; Gerken G; Treichel U
Liver Int; 2005 Feb; 25(1):101-8. PubMed ID: 15698406
[TBL] [Abstract][Full Text] [Related]
22. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
Lucena JF; Herrero JI
An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
[TBL] [Abstract][Full Text] [Related]
23. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
24. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
[TBL] [Abstract][Full Text] [Related]
25. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
26. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis.
Saab S; Niho H; Comulada S; Hiatt J; Durazo F; Han S; Farmer DG; Holt C; Yersiz H; Goldstein LI; Ghobrial RM; Busuttil RW
Liver Int; 2005 Oct; 25(5):940-5. PubMed ID: 16162150
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for hepatitis C recurrence after liver transplantation.
Roche B; Samuel D
J Viral Hepat; 2007 Nov; 14 Suppl 1():89-96. PubMed ID: 17958649
[TBL] [Abstract][Full Text] [Related]
28. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation.
Brillanti S; Vivarelli M; De Ruvo N; Aden AA; Camaggi V; D'Errico A; Furlini G; Bellusci R; Roda E; Cavallari A
Liver Transpl; 2002 Oct; 8(10):884-8. PubMed ID: 12360428
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW;
Liver Transpl; 2003 Apr; 9(4):339-47. PubMed ID: 12682883
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation in HIV/hepatitis co-infection.
Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
[TBL] [Abstract][Full Text] [Related]
31. Are posttransplantation protocol liver biopsies useful in the long term?
Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
[TBL] [Abstract][Full Text] [Related]
32. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
[TBL] [Abstract][Full Text] [Related]
33. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM
Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
[TBL] [Abstract][Full Text] [Related]
36. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.
Gane E
Liver Transpl; 2003 Nov; 9(11):S28-34. PubMed ID: 14586892
[TBL] [Abstract][Full Text] [Related]
37. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
Heneghan MA; Zolfino T; Muiesan P; Portmann BC; Rela M; Heaton ND; O'grady JG
Liver Transpl; 2003 Sep; 9(9):921-8. PubMed ID: 12942453
[TBL] [Abstract][Full Text] [Related]
39. Course and treatment of recurrent Hepatitis C after liver transplantation.
Neumann UP; Neuhaus P
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):61-6. PubMed ID: 15719007
[TBL] [Abstract][Full Text] [Related]
40. Treatment of recurrent hepatitis C after liver transplantation.
Biggins SW; Terrault NA
Clin Liver Dis; 2005 Aug; 9(3):505-23, ix. PubMed ID: 16023980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
